Warning: TLRY is at high risk of performing badly
Tilray Brands, Inc. (NASDAQ:TLRY) has characteristics which have been historically associated with poor future stock
Tilray Brands, Inc. (NASDAQ:TLRY) has characteristics which have been historically associated with poor future stock
Tilray Brands, Inc. (NASDAQ:TLRY) has characteristics which have been historically associated with poor future stock
Tilray Medical, a unit of Tilray Brands (NASDAQ:TLRY) said it has expanded its medical cannabis
rgbspace Shares of Canadian cannabis companies, including Canopy Growth (NASDAQ:CGC) and Tilray Brands (NASDAQ:TLRY), surged
wildpixel/iStock via Getty Images Tilray Brands (NASDAQ:TLRY) traded ~8% lower in the premarket on Friday
Tilray press release (NASDAQ:TLRY): Q2 Non-GAAP EPS of $0.00 beats by $0.01. Revenue of $211M
Tilray (NASDAQ:TLRY) is scheduled to announce Q2 earnings results on Friday, January 10th, before market
Summary: Tilray Brands has expanded its US (Beer / Delta-9 THC) and German operations (Medical